Bim and Mcl-1 in JAK2V617F Cell Survival
Author Information
Author(s): Rubert Joƫlle, Qian Zhiyan, Andraos Rita, Guthy Daniel A, Radimerski Thomas
Primary Institution: Novartis Institutes for BioMedical Research, Basel, Switzerland
Hypothesis
What roles do Bim and Mcl-1 play in regulating the survival of JAK2V617F mutant cells?
Conclusion
Bim and Mcl-1 have opposing roles in regulating JAK2V617F cell survival, and targeting both may enhance treatment efficacy.
Supporting Evidence
- Bim activation was triggered by JAK2 inhibition, leading to increased cell death.
- Depletion of Mcl-1 compromised cell viability and sensitized cells to JAK2 inhibition.
- Bim depletion suppressed JAK2 inhibitor-induced apoptosis in both SET-2 and MB-02 cells.
- JAK2 inhibition resulted in a drop in Mcl-1 levels and changes in Bim phosphorylation.
Takeaway
This study found that two proteins, Bim and Mcl-1, help decide if certain cancer cells live or die, and changing their levels could help treat the cancer better.
Methodology
The study used pharmacological inhibition, Western blot analysis, WST-1 proliferation assays, and flow cytometry to assess cell survival and apoptosis.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website